Podcast Episodes
Back to Search
Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
Season 25 Episode 29
Professor Claire Harrison from the Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom, and Dr John Mascarenas from The Tisch Cancer …
6 months, 4 weeks ago
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
Season 25 Episode 28
Dr Stephen Ansell from Mayo Clinic in Rochester, Minnesota, and Dr Brian Hill from Cleveland Clinic Taussig Cancer Institute in Ohio summarize major …
7 months ago
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
Season 25 Episode 27
Clinical investigators discuss available data guiding the management of systemic mastocytosis and myelofibrosis.
CME information and select publicat…
7 months, 1 week ago
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
Season 25 Episode 26
Clinical investigators discuss available data guiding the management of multiple myeloma.
CME information and select publications here.
7 months, 1 week ago
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Season 25 Episode 25
Dr Rafael Fonseca from Mayo Clinic in Phoenix, Arizona, discusses datasets from the 2024 ASH meeting on the management of newly diagnosed and relapse…
7 months, 1 week ago
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
Season 25 Episode 24
Dr Lindsey Roeker from Mayo Clinic in Rochester, Minnesota, discusses recent updates on available and novel treatment strategies for chronic lymphocy…
7 months, 2 weeks ago
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
Season 25 Episode 23
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick …
7 months, 2 weeks ago
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Season 25 Episode 22
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispeci…
7 months, 3 weeks ago
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
Season 25 Episode 21
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick …
7 months, 3 weeks ago
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
Season 25 Episode 20
Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma.
CME information and select publications here.
7 months, 4 weeks ago